These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25420649)
1. Bacteremia caused by Pseudomonas luteola in pediatric patients. Bayhan GI; Senel S; Tanir G; Ozkan S Jpn J Infect Dis; 2015; 68(1):50-4. PubMed ID: 25420649 [TBL] [Abstract][Full Text] [Related]
2. Brevundimonas vesicularis bacteremia resistant to trimethoprim-sulfamethoxazole and ceftazidime in a tertiary hospital in southern Taiwan. Zhang CC; Hsu HJ; Li CM J Microbiol Immunol Infect; 2012 Dec; 45(6):448-52. PubMed ID: 22516745 [TBL] [Abstract][Full Text] [Related]
3. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan. Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342 [TBL] [Abstract][Full Text] [Related]
4. [Accurate diagnosis of Pseudomonas luteola in routine microbiology laboratory: on the occasion of two isolates]. Çiçek M; Hasçelik G; Müştak HK; Diker KS; Şener B Mikrobiyol Bul; 2016 Oct; 50(4):621-624. PubMed ID: 28124968 [TBL] [Abstract][Full Text] [Related]
5. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175 [TBL] [Abstract][Full Text] [Related]
6. Flavimonas oryzihabitans bacteremia: clinical features and microbiological characteristics of isolates. Lin RD; Hsueh PR; Chang JC; Teng LJ; Chang SC; Ho SW; Hsieh WC; Luh KT Clin Infect Dis; 1997 May; 24(5):867-73. PubMed ID: 9142784 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia. Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint. Tam VH; Gamez EA; Weston JS; Gerard LN; Larocco MT; Caeiro JP; Gentry LO; Garey KW Clin Infect Dis; 2008 Mar; 46(6):862-7. PubMed ID: 18279040 [TBL] [Abstract][Full Text] [Related]
14. Severe catheter related bacteremia due to Pseudomonas luteola. Otto MP; Foucher B; Dardare E; Gérôme P Med Mal Infect; 2013 Apr; 43(4):170-1. PubMed ID: 23473706 [No Abstract] [Full Text] [Related]
15. Leg ulcer due to Pseudomanas luteola in a patient with sickle cell disease. Tsakris A; Hassapopoulou H; Skoura L; Pournaras S; Douboyas J Diagn Microbiol Infect Dis; 2002 Feb; 42(2):141-3. PubMed ID: 11858911 [TBL] [Abstract][Full Text] [Related]
16. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates. López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049 [TBL] [Abstract][Full Text] [Related]
17. A fatal case of Pseudomonas luteola infection. Ngoh E; Zohoun A; Ghazouani M; El Hamzaoui S; El Ouennass M Med Mal Infect; 2011 Jul; 41(7):399-400. PubMed ID: 21439742 [No Abstract] [Full Text] [Related]
18. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre. Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511 [TBL] [Abstract][Full Text] [Related]
19. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia]. Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors. Grisaru-Soen G; Lerner-Geva L; Keller N; Berger H; Passwell JH; Barzilai A Pediatr Infect Dis J; 2000 Oct; 19(10):959-63. PubMed ID: 11055596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]